QDEL - Quidel - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

QDEL is currently covered by 7 analysts with an average price target of $39.96. This is a potential upside of $12.57 (45.89%) from yesterday's end of day stock price of $27.39.

Quidel's activity chart (see below) currently has 85 price targets and 70 ratings on display. The stock rating distribution of QDEL is 37.5% HOLD, 37.5% BUY and 25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.87% with an average time for these price targets to be met of 82.89 days.

Highest price target for QDEL is $57, Lowest price target is $25, average price target is $49.4.

Most recent stock forecast was given by TYCHO PETERSON from JEFFERIES on 08-May-2025. First documented stock forecast 08-Jan-2016.

Currently out of the existing stock ratings of QDEL, 6 are a HOLD (37.5%), 6 are a BUY (37.5%), 4 are a SELL (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$44

$16.61 (60.64%)

$43

2 months 18 days ago
(08-May-2025)

7/8 (87.5%)

$7.54 (20.68%)

196

Sell

$25

$-2.39 (-8.73%)

$37

3 months 5 days ago
(21-Apr-2025)

3/5 (60%)

$0.44 (1.79%)

44

Hold

$45

$17.61 (64.29%)

$50

5 months 13 days ago
(13-Feb-2025)

1/3 (33.33%)

$3.35 (8.04%)

42

Buy

$57

$29.61 (108.11%)

$50

10 months 21 days ago
(05-Sep-2024)

5/13 (38.46%)

$12.5 (28.09%)

154

Buy

$76

$48.61 (177.47%)

$100

1 years 5 months 12 days ago
(14-Feb-2024)

2/9 (22.22%)

$30.73 (67.88%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is QDEL (Quidel) average time for price targets to be met?

On average it took 82.89 days on average for the stock forecasts to be realized with a an average price target met ratio 63.87

Which analyst has the current highest performing score on QDEL (Quidel) with a proven track record?

TYCHO PETERSON

Which analyst has the current lower performing score on QDEL (Quidel) with a proven track record?

JOHN SOURBEER

Which analyst has the most public recommendations on QDEL (Quidel)?

Tycho Peterson works at JEFFERIES and has 4 price targets and 6 ratings on QDEL

Which analyst is the currently most bullish on QDEL (Quidel)?

Steven Mah with highest potential upside - $112.61

Which analyst is the currently most reserved on QDEL (Quidel)?

Casey Woodring with lowest potential downside - -$2.39

Quidel in the News

5 Revealing Analyst Questions From QuidelOrtho’s Q1 Earnings Call

QuidelOrtho’s first quarter results received a strong positive reaction from the market, driven by better-than-expected profitability and stable core business performance despite a year-over-year revenue decline. Management attributed the quarter’s momentum to cost-saving initiatives and robust growth in its labs and immunohematology businesses. CEO Brian Blaser highlighted that, excluding COVID and donor screening, the company...

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading executives to its leadership team....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?